BDBM652539 (5-(5-(((1-amino-4-chloroisoquinolin-6-yl)amino)methyl)pyridin-2-yl)-4,5,6,7- tetrahydropyrazolo[1,5-a]pyrazin-4-yl)methanol::US20240059691, Example 1273

SMILES Nc1ncc(Cl)c2cc(NCc3ccc(nc3)N3CCn4nccc4C3CO)ccc12

InChI Key InChIKey=ZYINTEFXTIDKCX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 652539   

TargetCoagulation factor XII(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652539BDBM652539(US20240059691, Example 1273 | (5-(5-(((1-amino-4-c...)
Affinity DataIC50: 6.50E+3nMAssay Description:In vitro inhibition of Factor XIIa was determined using an IC50 assay based on standard literature methods (see e.g Baeriswyl et al., ACS Chem. Biol....More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652539BDBM652539(US20240059691, Example 1273 | (5-(5-(((1-amino-4-c...)
Affinity DataIC50: 7.00E+4nMAssay Description:In vitro inhibition of related proteases was determined using an (C50 assay based on standard literature methods (see e.g. Shori et al., Biochem. Pha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent